Home LiteratureArticle Details
PMID: 3112021 Published · ppublish ger Comparative Study Journal Article

[Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].

Prophylaxe gramnegativer und grampositiver Infektionen mit drei intravenösen Immunglobulin-Präparaten und Therapie der experimentellen polymikrobiellen Verbrennungssepsis mit intravenösem Pseudomonas-Immunglobulin G und Ciprofloxacin im Tiermodell.

Infection ·Vol. 15 Suppl 2 ·1987-00-00 ·Pages S51-9

Collins MS, Hector RF, Roby RE, Edwards AA, Ladehoff DK, Dorsey JH

Abstract

Three immunoglobulin preparations for intravenous infusion were compared in vivo to determine their relative protective capacity against several gram-negative and gram-positive pathogens. Polyglobin N is a conventional IgG concentrate. Psomaglobin N is identical in formulation to Polyglobin N but is prepared from the plasma of donors who have naturally high levels of antibody to lipopolysaccharide antigens of Pseudomonas aeruginosa. IgGMA is a conventional IgG concentrate containing 12% IgG and 16% IgA. In a murine model of burn wound sepsis the three IgG preparations were similarly protective against three or ten strains of P. aeruginosa. Psomaglobin N and Polyglobin N were significantly (p less than or equal to 0.015) more protective than IgGMA against six of ten and three of ten strains of P. aeruginosa, respectively. In a murine model of Streptococcus pneumoniae type 3 pneumonia, the three Ig preparations were similarly protective. IgGMA was significantly more protective (p less than or equal to 0.025) than Psomaglobin N and Polyglobin N against Salmonella typhimurium in murine peritonitis. However, the mean protective dose (PD50) of the two later preparations was less than or equal to 20 mg/kg body weight. In models of peritonitis both Psomaglobin N and Polyglobin N were more protective than IgGMA (p less than or equal to 0.004) against Haemophilus influenzae b, Klebsiella pneumoniae, Serratia marcescens 06:H3 and group B Streptococcus types 1b and 1c. Psomaglobin N and ciprofloxacin were employed to treat established polymicrobial murine burn wound sepsis resulting from contamination of the burn site with mixtures of P. aeruginosa and Staphylococcus aureus.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Animals Bacterial Infections/therapy Burns/therapy Ciprofloxacin/therapeutic use Combined Modality Therapy Female Immunoglobulin G/therapeutic use Mice Mice, Inbred Strains Pseudomonas Infections/therapy Pseudomonas aeruginosa/immunology Staphylococcal Infections/therapy Streptococcal Infections/therapy Wound Infection/therapy
Chemicals
Immunoglobulin G Ciprofloxacin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Collins M S
Hector R F
Roby R E
Edwards A A
Ladehoff D K
Dorsey J H
References (27)
27 references, click to expand
  1. Evaluation of gamma globulin for prophylaxis against burn sepsis.
    Surgery. 1965 Nov;58(5):810-4 PMID: 4158592
  2. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
    Antimicrob Agents Chemother. 1984 Mar;25(3):331-5 PMID: 6721464
  3. Comparative in vivo activity between intravenous immune globulin prepared by reduction and alkylation or by low pH.
    J Infect Dis. 1985 Jun;151(6):1171-3 PMID: 3998515
  4. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Antimicrob Agents Chemother. 1984 Mar;25(3):319-26 PMID: 6232895
  5. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
    J Infect Dis. 1983 Jun;147(6):1090-8 PMID: 6406615
  6. Burn wound infection.
    J Trauma. 1981 Sep;21(9):753-6 PMID: 7277539
  7. The gamma globulins. 3. The antibody deficiency syndromes.
    N Engl J Med. 1966 Sep 29;275(13):709-15 contd PMID: 5331313
  8. Undegraded human immunoglobulin for intravenous use.
    Vox Sang. 1975;28(6):422-37 PMID: 807036
  9. Exotoxin production by clinical isolates of pseudomonas aeruginosa.
    Infect Immun. 1977 Mar;15(3):776-80 PMID: 404244
  10. Binding of protein A to some human gamma-globulins used intravenously.
    Vox Sang. 1981;40(6):395-402 PMID: 6794221
  11. A factor in human gamma globulin preparations active against Pseudomonas aeruginosa infect. in mice.
    Proc Soc Exp Biol Med. 1957 Jan;94(1):214-7 PMID: 13400919
  12. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Rev Infect Dis. 1986 Jul-Aug;8 Suppl 4:S426-33 PMID: 2944209
  13. Replacement therapy with modified immunoglobulin G in burn patients: preliminary kinetic studies.
    Am J Med. 1984 Mar 30;76(3A):175-80 PMID: 6424447
  14. New immunotype schema for Pseudomonas aeruginosa based on protective antigens.
    J Bacteriol. 1969 May;98(2):835-6 PMID: 4977486
  15. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
    Infect Immun. 1983 Mar;39(3):1072-9 PMID: 6404817
  16. Role of infection in mortality from severe burns. Evaluation of plasma, gamma-globulin, albumin and saline-solution therapy in a group of Peruvian children.
    N Engl J Med. 1962 Aug 16;267:317-23 PMID: 14454824
  17. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection.
    Infect Immun. 1979 Apr;24(1):181-7 PMID: 110690
  18. Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.
    Proc Natl Acad Sci U S A. 1985 Mar;82(6):1790-4 PMID: 3856860
  19. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Am J Med. 1984 Mar 30;76(3A):168-74 PMID: 6424446
  20. Studies on the immunotherapy of bacterial infections. I. The comparative effectiveness of human gamma-globulin against various bacterial species in mice.
    J Immunol. 1958 Jul;81(1):29-31 PMID: 13563876
  21. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
    J Infect Dis. 1977 Aug;136 Suppl:S181-5 PMID: 70492
  22. Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice.
    J Trauma. 1983 Jun;23(6):530-4 PMID: 6408266
  23. [Properties and efficacy of a human immunoglobulin M preparation for intravenous administration].
    Arzneimittelforschung. 1985;35(6):933-6 PMID: 4026919
  24. Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera.
    J Immunol. 1975 Jun;114(6):1779-84 PMID: 805178
  25. Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation.
    Infect Immun. 1973 Aug;8(2):278-90 PMID: 4542033
  26. Supportive therapy in burn care. An overview of infection control.
    J Trauma. 1979 Nov;19(11 Suppl):879-80 PMID: 490712
  27. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.
    Antimicrob Agents Chemother. 1984 Nov;26(5):757-61 PMID: 6517559
Article Info
Journal
Infection
Abbr.
Infection
ISSN
0300-8126
Published
1987-00-00
Pages
S51-9
Language
ger
Region
Germany
NLM ID
0365307
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com